Journal
EMERGENT MATERIALS
Volume 6, Issue 4, Pages 1259-1272Publisher
SPRINGERNATURE
DOI: 10.1007/s42247-023-00520-0
Keywords
Antiviral; Cytotoxicity; SARS-CoV-2; Covid-19; Nanocomposites
Categories
Ask authors/readers for more resources
Self-virucidal Ag-TiO2 nanocomposites at low toxicity dose have the potential to reduce the risks of SARS-CoV-2 infection and excessive disinfectant usage. The nanocomposites show high virucidal efficacy at high doses, damaging the viral genome within 1 minute, and significant reduction of viral infectivity and cytotoxicity at low doses. The results suggest that Ag-TiO2 nanocomposites can be a more eco-friendly and safer disinfectant option with broad spectrum action against SARS-CoV-2 variants.
Self-virucidal Ag-TiO2 nanocomposites at low toxicity dose could be a viable solution to reduce the risks posed by SARS-CoV-2 infection and excessive usage of disinfectants. We synthesized an Ag-TiO2 nanocomposite suspension in a simple, low energy consumption, eco-friendly, one-pot process. PVP and SDS were used in a 3:1 ratio as co-stabilizers, resulting in a uniform size with high stability. The nanocomposite characterization used UV-Vis spectroscopy, high-resolution transmission-electron-microscopy equipped with an energy dispersive X-ray spectroscope (HR-TEM, EDX), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS). We determined the virucidal efficacy against SARS-CoV-2 by following ASTM E1052-20. The cytotoxicity test followed ISO 10993-5:2009. At high doses (50 ppm), the Ag-TiO2 nanocomposite suspension showed >= 99.96% virucidal efficacy within 1 min, damaging the viral genome. At a low dosage (0.8 ppm), the viral infectivity was reduced by 99.86% within 24 h and minimized cytotoxicity. The viral protein had denatured, while the viral genome remained intact. The results suggest that the Ag-TiO2 nanocomposite can be used in a more eco-friendly and safer manner as a potent broad spectrum virucidal disinfectant, offering broad action against unspecified targets (all virus proteins, not just the spike proteins), which could be helpful in all SARS-CoV-2 variants of concern.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available